跳至主要内容
临床试验/CTRI/2025/02/080613
CTRI/2025/02/080613尚未招募3 期

COMPARISON OF THE EFFICACY OF INHALATIONAL, INTRANASAL AND ORAL SEDATIVES IN PEDIATRIC DENTAL PATIENT MANAGEMENT: A RANDOMIZED CONTROLLED TRIAL

Dr Aanchal Singh1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年2月25日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
120
试验地点
1
主要终点
Level of sedation of the patient will be assessed by Modified

研究概览

简要总结

Dental fear significantly impacts pediatric dentistry, with prevalence ranging from 5.7% to 19.5%, often deterring children from regular visits and increasing oral health risks. Addressing dental anxiety is crucial to improving immediate care and preventing long-term oral health issues. Non-pharmacological methods like Tell-Show-Do, distraction, and cognitive-behavioral therapy (CBT) are effective, while pharmacological options, including sedation, are necessary for some patients.

Conscious sedation, using agents like midazolam, triclofos, and nitrous oxide, plays a key role in managing dental anxiety. Each sedation method has distinct benefits, with nitrous oxide offering rapid onset and recovery, intranasal midazolam providing effective anxiolysis, and triclofos acting as an oral sedative. However, limited randomized clinical trials compare their efficacy. This study aims to evaluate the sedative effectiveness of nitrous oxide, intranasal midazolam, and oral triclofos in pediatric dental patients

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant, Investigator and Outcome Assessor Blinded

入排标准

年龄范围
4.00 Year(s) 至 8.00 Year(s)(—)
性别
All

入选标准

  • Anxious children aged between 4-8 years.
  • Children having a physical status of ASA I according to the American Society of Anaesthesiologists.
  • Children having Frankl behaviour rating scale- positive.
  • Children who require a dental procedure under local anaesthesia.
  • Fasting status of children – light meal 2 hours before undergoing dental procedure.

排除标准

  • Very uncooperative children (frankl behaviour rating – definitive negative) .
  • Children who recently used medications like erythromycin or anticonvulsants that may interfere with the pharmacokinetics of midazolam.
  • Children with known hypersensitivity to nitrous oxide -oxigen sedation, intranasal midazolam and triclofos.
  • Children with any systemic disease and special health care needs.
  • Children with any condition that predisposes them to airway obstruction or difficulties (eg COPD, allergic rhinitis, adenoid hyperplasia, nasal septum problems, enlarged turbinates or nasal polyp).
  • Children with upper or lower respiratory tract infections.

结局指标

主要结局

Level of sedation of the patient will be assessed by Modified

时间窗: immediate

Ramsay sedation sale.

时间窗: immediate

pain perception will be assessed by using wong-baker faces pain

时间窗: immediate

rating scale.

时间窗: immediate

次要结局

  • overall behaniour will be asses by using Houpt Sedation Rating(Scale.)

研究者

发起方
Dr Aanchal Singh
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Aanchal Singh

Subharti Dental College and Hospital

研究点 (1)

Loading locations...

相似试验